ArticleEuropean journal of medical research2025

Safety assessment of ustekinumab in inflammatory bowel disease: a real-world analysis based on the FDA adverse event reporting system (FAERS).

Likang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.